经颅聚焦超声局部破坏血液白蛋白-苯妥英结合
本研究报道使用250 kHz脉冲式聚焦超声(55毫秒 burst、4 Hz脉冲重复)无创、空间特异性地破坏苯妥英与白蛋白的血浆蛋白结合。体外透析显示超声组未结合苯妥英浓度较未超声对照组升高27.7%;大鼠单侧脑半球超声后脑实质苯妥英摄取较未超声半球增加,未见温度变化或血脑屏障破坏证据。
要点
- 250 kHz脉冲聚焦超声可局部升高未结合苯妥英浓度,体外较对照升高27.7%。
- 大鼠单侧脑超声后脑实质苯妥英摄取较对侧增加,无温度变化或血脑屏障破坏。
- 聚焦超声或可作为空间选择性破坏药物-血浆蛋白结合的新技术。
诊断标准与关键数值
- 体外超声组未结合苯妥英浓度较未超声对照组升高27.7%。
- 大鼠超声半球脑实质苯妥英摄取较未超声半球增加,未见温度变化或血脑屏障破坏证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Plasma protein binding (PPB) plays an important role in drug pharmacokinetics, particularly for central nervous system drugs, as PPB affects the blood concentration of unbound drug available to cross the blood-brain barrier (BBB). We report the non-invasive, spatially specific disruption of PPB to phenytoin, an anti-epileptic drug with high affinity to albumin, using 250-kHz focused ultrasound (FUS) delivered in a pulsed manner (55-ms tone burst duration, 4-Hz pulse repetitions). Equilibrium dialysis performed on sonicated phosphate-buffered saline solution containing phenytoin and bovine serum albumin revealed a 27.7% elevation in the unbound phenytoin concentration compared with an unsonicated control. Sonication of a unilateral brain hemisphere in rats (n = 10) after intraperitoneal phenytoin injection revealed increased parenchymal phenytoin uptake compared with the unsonicated hemisphere, without evidence of temperature change or BBB disruption. These findings illustrate the use of FUS as a novel technique for spatially selective disruption of PPB, which may be applied to a wide range of drug-plasma protein interactions.
引用
- Xu L, Lee W, Rotenberg A, et al. Localized Disruption of Blood Albumin-Phenytoin Binding Using Transcranial Focused Ultrasound. Ultrasound Med Biol. 2020. PMID: 32402673. doi:10.1016/j.ultrasmedbio.2020.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。